Skip to main content
SpringerLink
Log in

Treatment of Dysarthria in Parkinson Disease

  • Chapter
  • First Online:
Therapy of Movement Disorders

Part of the book series: Current Clinical Neurology ((CCNEU))

  • 2031 Accesses

Abstract

Voice and speech disorders occur in up to 89% of people with Parkinson disease (PD). The most common perceptual characteristics include reduced vocal loudness, monotone, hoarse or breathy voice quality, and imprecise articulation. The Lee Silverman Voice Treatment (LSVT LOUD®) is an effective speech therapy to improve vocal loudness and functional communication in people with PD. This case study will illustrate classic voice and speech symptoms in a person with moderate PD and the positive outcomes following LSVT LOUD treatment. The rationale and efficacy data of this treatment approach will be discussed.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 119.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Hardcover Book
USD 159.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Suggested Reading

  • Dumer AI, Oster H, McCabe D, Rabin LA, Spielman JL, Ramig L, Borod JC. Effects of the Lee Silverman voice treatment on facial expressivity in Parkinson’s disease. J Int Neuropsychol Soc. 2014;20(3):302–12.

    Article  Google Scholar 

  • El-Sharkawi A, Ramig L, Logemann J, Pauloski B, Rademaker A, Smith C, Pawlas A, Baum S, Werner C. Swallowing and voice effects of lee Silverman voice treatment: a pilot study. J Neurol Neuropsychiatry Psychiatry. 2002;72(1):31–6.

    Article  CAS  Google Scholar 

  • Fox C, Ramig L, Ciucci M, Sapir S, McFarland DH, Farley B. Science and practice of LSVT/LOUD: neural plasticity-principled approach to treating individuals with Parkinson disease and other neurological disorders. Semin Speech Lang. 2006;27:283–99.

    Article  Google Scholar 

  • Halpern A, Ramig L, Matos C, Petska-Cable J, Spielman J, Pogoda J, Gilley P, Sapir S, Bennett J, McFarland D. Innovative technology for the assisted delivery of intensive voice treatment (LSVT®LOUD) for Parkinson disease. Am J Speech Lang Pathol. 2012;21(4):354–67.

    Article  Google Scholar 

  • Mahler LA, Ramig LO, Fox C. Evidence-based treatment of voice and speech disorders in Parkinson disease. Curr Opin Otolaryngol Head Neck Surg. 2015;23(3):209–15.

    Article  Google Scholar 

  • Narayana S, Fox PT, Zhang W, Franklin C, Robin DA, Vogel D, Ramig L. Neural correlates of efficacy of voice therapy in Parkinson’s disease identified by performance-correlation analysis. Hum Brain Mapp. 2010;31:222–36.

    PubMed  PubMed Central  Google Scholar 

  • Ramig L, Halpern A, Spielman J, Fox C, Freeman K. Speech treatment in Parkinson’s Disease: Randomized Controlled Trial (RCT). Mov Disord. In Press.

    Google Scholar 

  • Ramig L, Countryman S, Thompson L, Horii Y. A comparison of two forms of intensive speech treatment for Parkinson disease. J Speech Hearing Res. 1995;38:1232–51.

    Article  CAS  Google Scholar 

  • Ramig L, Dromey C. Aerodynamic mechanisms underlying treatment related changes in SPL in patients with Parkinson disease. J Speech Hear Res. 1996;39:798–807.

    Article  CAS  Google Scholar 

  • Ramig L, Fox C, Sapir S. Speech and voice disorders in Parkinson disease. In: Olanow W, Stocchi W, Lang A, editors. The Non-motor and non-dopaminergic Features of Parkinson disease. Oxford, UK: Blackwell Publishing; 2011. p. 348–62.

    Google Scholar 

  • Ramig L, Sapir S, Countryman S, Pawlas A, O’Brien C, Hoehn M, Thompson L. Intensive voice treatment for individuals with Parkinson disease: a two-year follow-up. J Neurol Neurosurg Psychiatry. 2001a;71:493–8.

    Article  CAS  Google Scholar 

  • Ramig L, Sapir S, Fox C, Countryman S. Changes in vocal intensity following intensive voice treatment (LSVT) in individuals with Parkinson disease: a comparison with untreated patients and normal age-matched controls. Mov Disord. 2001b;16:79–83.

    Article  CAS  Google Scholar 

  • Sapir S, Spielman J, Ramig L, Story B, Fox C. Effects of intensive voice treatment (LSVT®) on vowel articulation in dysarthric individuals with idiopathic Parkinson’s disease: acoustic and perceptual findings. J Speech Language Hearing Res. 2007;50:899–912.

    Article  Google Scholar 

  • Smith ME, Ramig L, Dromey C, Perez KS, Samandari R. Intensive voice treatment in Parkinson’s disease: Laryngostroboscopic findings. J Voice. 1995;9:453–9.

    Article  CAS  Google Scholar 

  • Spielman J, Mahler L, Halpern A, Gilley P, Klepitskaya O, Ramig L. Intensive voice treatment (LSVT®LOUD) for Parkinson’s disease following deep brain stimulation of the subthalamic nucleus. J Commun Disord. 2011;44:688–700.

    Article  Google Scholar 

  • Theodoros DG, Hill AJ, Russell TG. Clinical and quality of life outcomes of speech treatment for Parkinson’s disease delivered to the home via Telerehabilitation: a noninferiority randomized controlled trial. Am J Speech Lang Pathol. 2016;25(2):214–32.

    Article  Google Scholar 

  • Theodoros D, Ramig L. Communication and swallowing in Parkinson’s disease. San Diego: Plural Publishing; 2011.

    Google Scholar 

Download references

Author information

Authors and Affiliations

  1. University of Colorado, Boulder, CO, USA

    Lorraine A. Ramig PhD, CCC-SLP

  2. National Center for Voice and Speech, Denver, CO, USA

    Lorraine A. Ramig PhD, CCC-SLP & Cynthia M. Fox PhD, CCC-SLP

  3. Columbia University, New York City, NY, USA

    Lorraine A. Ramig PhD, CCC-SLP

  4. LSVT Global, Inc., Tucson, AZ, USA

    Lorraine A. Ramig PhD, CCC-SLP & Cynthia M. Fox PhD, CCC-SLP

Authors
  1. Lorraine A. Ramig PhD, CCC-SLP
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Cynthia M. Fox PhD, CCC-SLP
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Lorraine A. Ramig PhD, CCC-SLP .

Editor information

Editors and Affiliations

  1. The Frederick Henry Prince Distinguished, Professor in Neurology, Department of Neurology, University of Maryland, Baltimore, Baltimore, MD, USA

    Stephen G. Reich

  2. Vance Lanier Chair of Neurology, Professor, Department of Neurology, Director, Jean and Paul Amos Parkinson’s Disease and Movement Disorder Program, Emory University, Atlanta, GA, USA

    Stewart A. Factor

Rights and permissions

Reprints and permissions

Copyright information

© 2019 Springer Nature Switzerland AG

About this chapter

Check for updates. Verify currency and authenticity via CrossMark

Cite this chapter

Ramig, L.A., Fox, C.M. (2019). Treatment of Dysarthria in Parkinson Disease. In: Reich, S., Factor, S. (eds) Therapy of Movement Disorders. Current Clinical Neurology. Humana, Cham. https://doi.org/10.1007/978-3-319-97897-0_9

Download citation

  • DOI: https://doi.org/10.1007/978-3-319-97897-0_9

  • Published:

  • Publisher Name: Humana, Cham

  • Print ISBN: 978-3-319-97896-3

  • Online ISBN: 978-3-319-97897-0

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics

Search

Navigation